Clinical Trial Update: Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating botulinum toxin type A versus placebo for post-stroke upper limb spasticity has completed, with efficacy and safety results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Spasticity of the Upper Limb

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Post-stroke Spasticity of the Upper Limb | Phase 3 | Status: COMPLETED | Results posted: 2016-02-11